-
Mashup Score: 0The ORIOLE Trial Results Discussed: Outcomes of Observation vs SABR for Oligometastatic Prostate Cancer - Phuoc T. Tran - 4 year(s) ago
The ORIOLE Phase 2 Randomized Clinical Trial set out to answer the question, “how effectively does stereotactic ablative radiotherapy prevent progression of disease compared with observation in men with recurrent hormone-sensitive prostate cancer with 1 to 3 metastases?” Dr. Tran joins Alicia Morgans and discusses this phase 2 randomized clinical trial of 54 men, where the progression of…
Source: UroTodayCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0The ORIOLE Trial Results Discussed: Outcomes of Observation vs SABR for Oligometastatic Prostate Cancer - Phuoc T. Tran - 4 year(s) ago
The ORIOLE Phase 2 Randomized Clinical Trial set out to answer the question, “how effectively does stereotactic ablative radiotherapy prevent progression of disease compared with observation in men with recurrent hormone-sensitive prostate cancer with 1 to 3 metastases?” Dr. Tran joins Alicia Morgans and discusses this phase 2 randomized clinical trial of 54 men, where the progression of…
Source: UroTodayCategories: UrologyTweet
The #ORIOLE trial - stereotactic ablative radiotherapy a promising treatment approach for men with recurrent hormone-sensitive oligometastatic #prostatecancer. #ListenNow > https://t.co/NPlt3JUpQt Phuoc Tho Tran, MD, PhD @HopkinsMedicine @CaPsurvivorship @NUFeinbergMed https://t.co/XbK290Ed3R